The International Society of Antimicrobial Chemotherapy (ISAC) are inviting nominations from Member societies such as the SMA for the Hamao Umezawa Memorial Award which is the highest award given by ISAC. Throughout his impressive career Professor Umezawa made many key discoveries in the fields of antibiotics and anti-cancer drugs.
Purpose
The HUMA is intended to honour individual researchers, scientists or clinicians who have made outstanding contributions in the field of antimicrobial chemotherapy. The award may be given for individual pieces of meritorious work or to honour an exceptional career in antimicrobial chemotherapy.
Award
10,000 Swiss Francs, a certificate and a medal will be bestowed upon the successful nominee at the 32nd ICC in Perth, Australia in 2022. The awardee will also receive a funded place at the Congress and will be expected to deliver a 40-minute lecture. A list of previous awardees, along with their lecture titles, may be found on the ISAC website.
Nomination Procedure
- Nominations are invited from ISAC Member Societies.
- Nominees may either work in the scientific arena or in the area of patient care.
- Member Societies should E-mail a letter stating the reasons for the nomination accompanied by a curriculum vitae (CV), bibliography and electronic copies of key publications representing the candidate’s work.
- Resubmission of an application made in a previous year should be accompanied by an updated CV and bibliography.
The above requirements (letter of nominations, CV of candidate and key publications) should be sent electronically to Dr Fiona MacKenzie, ISAC Chief Executive Officer via secretariat@ISAC.world
Deadline for nominations is 31 October 2021.